These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

582 related items for PubMed ID: 15019389

  • 1. Tumor necrosis factor alpha blockade with infliximab for refractory uveitis and scleritis.
    Murphy CC, Ayliffe WH, Booth A, Makanjuola D, Andrews PA, Jayne D.
    Ophthalmology; 2004 Feb; 111(2):352-6. PubMed ID: 15019389
    [Abstract] [Full Text] [Related]

  • 2. Treatment of refractory posterior uveitis with infliximab: a 7-year follow-up study.
    Lopez-Gonzalez R, Loza E, Jover JA, Benitez Del Castillo JM, Mendez R, Hernandez-Garcia C, Pato E.
    Scand J Rheumatol; 2009 Feb; 38(1):58-62. PubMed ID: 18991187
    [Abstract] [Full Text] [Related]

  • 3. Differential effectiveness of etanercept and infliximab in the treatment of ocular inflammation.
    Galor A, Perez VL, Hammel JP, Lowder CY.
    Ophthalmology; 2006 Dec; 113(12):2317-23. PubMed ID: 16996615
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Long-term treatment of refractory posterior uveitis with anti-TNFalpha (infliximab).
    Benitez-del-Castillo JM, Martinez-de-la-Casa JM, Pato-Cour E, Méndez-Fernández R, López-Abad C, Matilla M, Garcia-Sanchez J.
    Eye (Lond); 2005 Aug; 19(8):841-5. PubMed ID: 15389273
    [Abstract] [Full Text] [Related]

  • 7. Long-term progression, prognosis, and treatment of patients with recurrent ocular manifestations of Reiter's syndrome.
    Kiss S, Letko E, Qamruddin S, Baltatzis S, Foster CS.
    Ophthalmology; 2003 Sep; 110(9):1764-9. PubMed ID: 13129875
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Infliximab therapy for the treatment of refractory ocular inflammatory disease.
    Sobrin L, Kim EC, Christen W, Papadaki T, Letko E, Foster CS.
    Arch Ophthalmol; 2007 Jul; 125(7):895-900. PubMed ID: 17620567
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behçet's disease: an open-label trial.
    Tugal-Tutkun I, Mudun A, Urgancioglu M, Kamali S, Kasapoglu E, Inanc M, Gül A.
    Arthritis Rheum; 2005 Aug; 52(8):2478-84. PubMed ID: 16052571
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [The treatment of recurrent uveitis with TNF-alpha inhibitors].
    Falappone PC, Iannone F, Scioscia C, Grattagliano V, Covelli M, Lapadula G.
    Reumatismo; 2004 Aug; 56(3):185-9. PubMed ID: 15470524
    [Abstract] [Full Text] [Related]

  • 14. Adverse events and efficacy of TNF-alpha blockade with infliximab in patients with systemic lupus erythematosus: long-term follow-up of 13 patients.
    Aringer M, Houssiau F, Gordon C, Graninger WB, Voll RE, Rath E, Steiner G, Smolen JS.
    Rheumatology (Oxford); 2009 Nov; 48(11):1451-4. PubMed ID: 19748965
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Infliximab effects compared to conventional therapy in the management of retinal vasculitis in Behçet disease.
    Tabbara KF, Al-Hemidan AI.
    Am J Ophthalmol; 2008 Dec; 146(6):845-50.e1. PubMed ID: 18929351
    [Abstract] [Full Text] [Related]

  • 18. Loss of efficacy during long-term infliximab therapy for sight-threatening childhood uveitis.
    Simonini G, Zannin ME, Caputo R, Falcini F, de Martino M, Zulian F, Cimaz R.
    Rheumatology (Oxford); 2008 Oct; 47(10):1510-4. PubMed ID: 18676502
    [Abstract] [Full Text] [Related]

  • 19. Infliximab for chronic cystoid macular edema associated with uveitis.
    Markomichelakis NN, Theodossiadis PG, Pantelia E, Papaefthimiou S, Theodossiadis GP, Sfikakis PP.
    Am J Ophthalmol; 2004 Oct; 138(4):648-50. PubMed ID: 15488796
    [Abstract] [Full Text] [Related]

  • 20. Tumour necrosis factor alpha inhibitors in the treatment of childhood uveitis.
    Saurenmann RK, Levin AV, Rose JB, Parker S, Rabinovitch T, Tyrrell PN, Feldman BM, Laxer RM, Schneider R, Silverman ED.
    Rheumatology (Oxford); 2006 Aug; 45(8):982-9. PubMed ID: 16461435
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.